Buscar resultados de ensayos clínicos
Lymphangioleiomyomatosis - 25 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: National Lymphangioleiomyomatosis Registry, France Condición: Lymphangioleiomyomatosis Fecha: 2011-11-30 |
Recruiting |
Nombre del estudio: Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM) Condición: Lymphangioleiomyomatosis Fecha: 2006-12-20 Intervenciones:
|
Completed |
Nombre del estudio: Pulmonary Rehabilitation in Lymphangioleiomyomatosis Condición: Lymphangioleiomyomatosis Fecha: 2013-12-04 Intervenciones: Other: Pulmonary Rehabilitation |
Completed |
Nombre del estudio: The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1) Condición: Pulmonary Lymphangioleiomyomatosis Fecha: 2014-04-15 Intervenciones: Drug: Saracatinib Saracatinib is escalated as follows: Three dose levels will be administered for 1 mont |
Completed |
Nombre del estudio: Trial of Aromatase Inhibition in Lymphangioleiomyomatosis Condición: Lymphangioleiomyomatosis Fecha: 2011-05-11 Intervenciones:
|
Completed |
Nombre del estudio: A Study to Determine the Effectiveness of Escalating Doses of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis Condición: Lymphangioleiomyomatosis Fecha: 2010-01-28 Intervenciones: Drug: Everolimus |
Recruiting |
Nombre del estudio: A Study of Nintedanib for LymphAngioleioMyomatosis (LAM) Condición: Lymphangioleiomyomatosis Fecha: 2016-10-07 Intervenciones: Drug: Nintedanib Other Name: OFEV |
Recruiting |
Nombre del estudio: Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis Condición: Lymphangioleiomyomatosis Fecha: 2013-02-23 Intervenciones:
|
Recruiting |
Nombre del estudio: Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis Condición: Pulmonary Lymphangioleiomyomatosis Fecha: 2016-03-31 Intervenciones: Drug: saracatinib Subjects will receive enough tablets for 90 days +/- 14 days at each visit. Subject wi |
Completed |
Nombre del estudio: Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis Condición: Lymphangioleiomyomatosis Fecha: 2012-08-02 Intervenciones: Drug: sirolimus and hydroxychloroquine This will be a phase I dose escalation study of the combination o |